Stephen Tulipano
Director of Finance/CFO bij STOKE THERAPEUTICS, INC.
Vermogen: 280 071 $ op 31-03-2024
Actieve functies van Stephen Tulipano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
STOKE THERAPEUTICS, INC. | Director of Finance/CFO | 01-03-2019 | - |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Massachusetts Society of Certified Public Accountants, Inc. provide services in public accounting, industry and business, government and education. The firm offers advocacy, continuing professional education, peer review, membership, communications and academic and career development department. The company was founded in 1900 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Loopbaan van Stephen Tulipano
Eerdere bekende functies van Stephen Tulipano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 23-06-2014 | 31-07-2018 |
Investor Relations Contact | 23-06-2014 | 31-07-2018 | |
Treasurer | 23-06-2014 | 31-07-2018 | |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01-05-2006 | 01-07-2010 |
Corporate Secretary | 22-07-2009 | 01-07-2010 | |
BIOGEN INC. | Comptroller/Controller/Auditor | 01-10-1998 | 01-04-2006 |
Digital Equipment Corp. | Corporate Officer/Principal | - | - |
Opleiding van Stephen Tulipano
Salem State University | Undergraduate Degree |
Sawyer Business School | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Corporate Secretary | 1 |
Sectoraal
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIOGEN INC. | Health Technology |
ALDEYRA THERAPEUTICS, INC. | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Digital Equipment Corp. | Electronic Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Massachusetts Society of Certified Public Accountants, Inc. provide services in public accounting, industry and business, government and education. The firm offers advocacy, continuing professional education, peer review, membership, communications and academic and career development department. The company was founded in 1900 and is headquartered in Boston, MA. | Commercial Services |
- Beurs
- Insiders
- Stephen Tulipano
- Ervaring